FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> Daiichi Sankyo

Daiichi sets up vaccine R&D; unit in Japan

Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!



Tools

Daiichi Sankyo has established a new Tokyo-based vaccine research unit at its existing Kasai R&D Center in Japan. The move follows the April announcement that Daiichi had set up another research unit inside the National Institute of Biomedical Innovation in Osaka, where the Japanese developer says it's already conducting exploratory vaccine research and searching for new adjuvants.

Researchers at the Tokyo unit will be hunting for new vaccines for infectious diseases, according to Daiichi's release. "Now, with two vaccine research units and partnerships with organizations inside and outside of the group, Daiichi Sankyo is poised to fully realize its dedication to producing new vaccines through continuing research efforts and to supplying safe and effective existing vaccines to the healthcare professionals and other persons in Japan who are waiting for them," the pharma company said in a statement.

- see this release from Daiichi

Related Article:
Daiichi shuffles R&D programs in global restructuring


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceVaccines Email Newsletter:

More stories about Daiichi Sankyo